// March 12, 2021
Nitrosamine impurities in medicines: what’s the risk?
In simple terms, risk is the possibility of something bad happening.
Edmond Biba, Ph.D.
Senior Scientific Liaison for USP General Chapters
Dr. Edmond Biba is USP’s Senior Scientific Liaison to the USP General Chapters-Chemical Analysis Expert Committee and USP General Chapters-Physical Analysis Expert Committee. Since joining USP in 2001, Dr. Biba served as a scientist in the Research and Development Laboratory and in the Reference Standards Evaluation Department.
Prior to joining USP, Dr. Biba was a National Research Council-Walter Reed Army Institute of Research Postdoctoral Fellow in the Medicinal Chemistry Department of Experimental Therapeutic Division conducting research on bioassay directed drug discovery and mechanism of action-based design and the synthesis of new antimalarial drug candidates. Dr. Biba received his Ph.D. in Chemistry-Synthetic Chemistry from the American University, Washington DC, and a B.Sc. in Chemical Engineering/Chemistry from University of Tirana, Tirana, Albania.
Dr. Biba is member of Sigma Xi, The Scientific Research Honor Society, American Chemical Society, American Association of Pharmaceutical Scientists, and a member of Pharmaceutical Quality Technical Committee of the Pharmaceutical Quality Research Institute (PQRI).